Pernix Therapeutics to Report First Quarter 2017 Financial Results on Monday, May 15

MORRISTOWN, N.J., May 08, 2017 (GLOBE NEWSWIRE) — Pernix Therapeutics Holdings, Inc. (PTX) a specialty pharmaceutical company, announced today that the Company will report financial results for the first quarter ended March 31, 2017, after the market close on Monday, May 15, 2017.  John Sedor, Chairman and Chief Executive Officer, and Graham Miao, President and Chief Financial Officer, will host a conference call to discuss the results.